BridgeMD
Compares treatment options for Critical Illness
Official title Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)
ClinicalTrials.gov ID: NCT06721923
What this study is testing
- What it's testing
- The goal of this intervention study is to evaluate the difference in nutrition status markers (weight and muscle mass) when giving dietary protein by continuous or bolus delivery in critically ill children ages 1-11y. The main questions it aims to answer are: Primary: Bolus protein delivery will lessen the decline in mid-upper arm circumference (MUAC) z-score by 0.5 standard deviation in critically ill children aged 1-11y after 1wk.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 11
You may be able to join if
- Children admitted to PICU over 1 year of age and younger than 11 years of life
- Expected to remain in the pediatric intensive care unit for longer than 72 hours
- Receiving standard pediatric formula via NGT/OGT/GT
You likely can't join if
- Neuromuscular condition such as muscular dystrophy
- Admitted with home prescription for high dose steroids, receives growth hormone or insulin
- Enteral nutrition is contraindicated or if nutrition requirements are partially/fully met by parenteral nutrition
- Formula delivered into the small bowel (duodenum/jejunum, NJT/GJ)
- Those who require a highly specialized diet (E.g., large burns or metabolic diseases)
- Patients with a cow's milk protein allergy cannot safely receive a whey-based protein supplement
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 11 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.